FX Shoulder Solutions Retrospective / Prospective Clinical Study

ConditionsRotator Cuff Syndrome of Shoulder and Allied Disorders Osteoarthritis Shoulder Fracture, Shoulder

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorFX Shoulder Solutions

About this trial

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

Eligibility criteria

Qualifiers

Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023.

Disqualifiers

Patient who does not meet the inclusion criteria above

Trial design

Treatments tested in this trial

FX Artificial Shoulder Prosthesis

Treatment groups

600 Participants

are divided into 1 treatment group

Sponsors and collaborators

FX Shoulder Solutions

Lead sponsor

Source ClinicalTrials.gov